Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

AM Rx vs Direct Meds

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

5.9

AM Rx

Best for patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully)
★★★☆☆3

Starting at $25/mo

Compounded SemaglutideOzempicWegovyZepbound
Visit AM Rx
5.4

Direct Meds

Best for listed for transparent disclosure — see FDA warning and BBB complaint pattern before considering
★★☆☆2.7

Starting at $249/mo

CompoundedSemaglutideTirzepatideSublingual Option
Visit Direct Meds

Side-by-Side Comparison

FeatureAM RxDirect Meds
Overall Score5.9/105.4/10
Starting Price$25/mo$249/mo
Editorial Rating3 ★ /52.7 ★ /5
Features6 features5 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA Warnings2 warnings1 warning

Pros & Cons

AM Rx

Pros

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available (not just async) with providers averaging 10+ years experience
  • Compounded semaglutide from $151/mo quarterly

Cons

  • Active FTC/DOJ lawsuit for deceptive billing and subscription practices (ROSCA violations)
  • Two FDA warning letters (Sept 2025, Feb 2026) for misbranding compounded GLP-1 products
  • Novo Nordisk false advertising lawsuit (Aug 2025)
  • Parent entity Zealthy has BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5 — 85% one-star reviews citing billing disputes and unreachable support
  • No visible LegitScript certification or PCAB accreditation
  • No named pharmacy partners — compounding source not disclosed
  • No FDA compounding disclaimer on the website
  • State availability not publicly disclosed
  • Founder Kyle Robertson previously ran Cerebral, which settled FTC charges for similar practices
  • Same corporate entity (FitRX LLC) as Zealthy and FitRx — shares regulatory history

Direct Meds

Pros

  • Both semaglutide and tirzepatide available in injection and sublingual formats
  • All-inclusive pricing with medication, consultations, supplies, and 1–2 day temperature-controlled shipping
  • LegitScript certification confirmed (verified December 2025)
  • Named 503A pharmacy partners: CraftedRx (Warrenton, MO) and ChemistryRx (Folcroft, PA)

Cons

  • FDA warning letter September 9, 2025 for misleading marketing of compounded GLP-1s as equivalent to FDA-approved drugs — compliance status post-warning not publicly documented
  • Extensive Better Business Bureau complaint pattern (rating 1.12/5 across 226 reviews as of April 2026) documenting a hidden 3-month commitment trap: multiple users report being charged $940+ for a 3-month supply when they believed they were purchasing 1 month. Direct Meds disputes the characterization but the complaint volume is material
  • Katalys program name 'Direct Meds GLP-1 Offers Top Funnels' and $280 CPA payout indicate aggressive performance-marketing optimization, which can correlate with conversion-first UX patterns
  • Rating discrepancy: Trustpilot 4.6/5 from 7,500+ reviews vs. BBB 1.12/5 from 226 reviews — suggests either review-solicitation bias or genuine unresolved customer experience issues
  • Not available in Mississippi, Louisiana, or California
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Incorporated May 2024 — less than 2 years of operational history
  • Auto-renewal continues until manual email cancellation; BBB complaints report retention-department friction and hold times exceeding 15 minutes

Our Verdict

Winner: AM RxScore: 5.9/10

AM Rx edges out Direct Meds with a higher overall score of 5.9/10 and is particularly strong for patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully). Direct Meds remains a solid alternative, especially if you're looking for listed for transparent disclosure — see FDA warning and BBB complaint pattern before considering.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.